|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"han kwang hyub"
Showing items 21-24 of 24 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2009-10-30 |
LONG-TERM ENTECAVIR THERAPY RESULTS IN REVERSAL OF FIBROSIS/CIRRHOSIS AND CONTINUED HISTOLOGIC IMPROVEMENT IN PATIENTS WITH HBEAG(+)AND (-) CHRONIC HEPATITIS B: RESULTS FROM STUDIES ETV-022, -027 AND -901
|
Liaw, Yun-Fan; Chang, Ting-Tsung; Wu, Shun-Sheng; Eugene R. Schiff; Han, Kwang-Hyub; Lai, Ching-Lung; Rifaat Safadi; Lee, Samuel S.; Waldemar Halota; Zachary D. Goodman; Zhang, Hui; Robert Hindes; Uchenna Iloeje; Suzanne Beebe11; Bruce Kreter |
| 國立成功大學 |
2007-11 |
Entecavir therapy for up to 96 weeks in patients with HBeAg-Positive chronic hepatitis B
|
Gish, Robert G.; Lok, Anna S.; Chang, Ting-Tsung; De Man, Robert A.; Gadano, Adrian; Sollano, Jose; Han, Kwang-Hyub; Chao, You-Chen; Lee, Shou-Dong; Harris, Melissa; Yang, Joanna; Colonno, Richard; Brett-Smith, Helena |
| 國立成功大學 |
2006-03-09 |
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
|
Chang, Ting-Tsung; Gish, Robert G.; de Man, Robert; Gadano, Adrian; Sollano, Jose; Chao, You-Chen; Lok, Anna S.; Han, Kwang-Hyub; Goodman, Zachary; Zhu, Jin; Cross, Anne; DeHertogh, Deborah; Wilber, Richard; Colonno, Richard; Apelian, David |
| 國立成功大學 |
2006-03 |
Entecavir (ETV) treatment through 96 weeks results in substantial virologic and biochemical improvement and HBeAg seroconversion in HBeAg(+) chronic hepatitis B (CHB) patients (study ETV-022)
|
Chang, Ting-Tsung; Chao, You-Chen; Sollano, Jose; Han, Kwang-Hyub; Lai, Ching-Lung; Lao-Tan, Judy; Akbar, Nurul; Zhu, Jin; Cross, Anne; Brett-Smith, Helena; Neo, Boon-Leong |
Showing items 21-24 of 24 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
